“You may’t have that safer source without the need of there staying a source,” he explained, introducing that they’re mostly aiming to sell to researchers and front-line workers in lieu of directly to drug buyers.“We're currently exploring strategies to leverage our abilities and global connections to facilitate the efforts of scientists